Reduction of quality-adjusted life years (QALYs) in patients with premenstrual dysphoric disorder (PMDD)
Authors:
- 3 July 2017
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 26 (11) , 3069-3073
Abstract
Purpose Premenstrual dysphoric disorder (PMDD) refers to the depression that occurs during the premenstrual phase and remits soon after the onset of menses. It affects the quality of life (QOL) of patients with PMDD. Therefore, this preliminary survey from chart recordings aimed to understand the symptom appearance and QOL reduction patterns in patients with PMDD, and to examine the extent of the loss of their quality-adjusted life years (QALYs). Methods Participants were 66 untreated female patients with PMDD. Data on symptom appearance and QOL reduction during the menstrual cycle, and the EuroQoL-5D (EQ-5D) scores during the premenstrual phase and immediately after the completion of a menstrual period were collected. Results The mean EQ-5D score of the 66 patients with PMDD was 0.795 ± 0.120 (range 0.362–0.949), indicating that their expected mean loss of QALYs was about 0.14 years. Conclusions If untreated, PMDD is expected to cause a mean loss of QALYs of about 0.14 years. However, on accounting for the period from disease development to menopause, and subtracting the menstruation-free periods such as pregnancy and breastfeeding, patients with untreated PMDD are expected to experience a QALY loss of about 3 years during their lifetime.Keywords
Funding Information
- JSPS KAKENHI (JP26670544)
This publication has 16 references indexed in Scilit:
- Psychiatric Symptoms and Disorders Associated with Reproductive Cyclicity in Women: Advances in Screening ToolsWomen's Health, 2015
- Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in SingaporeQuality of Life Research, 2015
- A cross‐sectional assessment of health‐related quality of life (HRQoL) among hypertensive patients in PakistanHealth Expectations, 2012
- Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D)Clinical and Experimental Nephrology, 2010
- Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illnessExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and Premenstrual Dysphoric DisorderObstetrics & Gynecology, 2008
- Impact of psychiatric disorders on health-related quality of life: general population surveyThe British Journal of Psychiatry, 2007
- Premenstrual Syndrome, Premenstrual Dysphoric Disorder, and Beyond: A Clinical Primer for PractitionersObstetrics & Gynecology, 2004
- Estimating an EQ‐5D population value set: the case of JapanHealth Economics, 2002
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990